BSG and neoplasm: The expression of EMMPRIN has been directly identified by some authors as a potential biomarker of tumor progression and inflammation, due to its involvement in the induction of proteinases that cause the degradation of the extracellular matrix, tumor invasion and angiogenesis [10,11,12].